找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Evaluation: Methods in Clinical Pharmacology; Franz J. Hock,Michael R. Gralinski Living reference work 20200th edition

[復(fù)制鏈接]
查看: 51165|回復(fù): 60
樓主
發(fā)表于 2025-3-21 19:28:18 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology
編輯Franz J. Hock,Michael R. Gralinski
視頻videohttp://file.papertrans.cn/284/283074/283074.mp4
概述A landmark in the continuously changing world of drugs.Easy-to-use, method-orientated overview on all aspects of Clinical Pharmacology.Essential reading for pharmacologists, physicians, medicinal chem
圖書封面Titlebook: Drug Discovery and Evaluation: Methods in Clinical Pharmacology;  Franz J. Hock,Michael R. Gralinski Living reference work 20200th edition
描述.Drug Discovery and Evaluation has become a more and more difficult, expensive and time-consuming process. The effect of a new compound has to be detected by in vitro and in vivo methods of pharmacology. The activity spectrum and the potency compared to existing drugs have to be determined..As these processes can be divided up stepwise we have designed a book series "Drug Discovery and Evaluation" in the form of a .recommendation. document. The methods to detect drug targets are described in the first volume of this series "Pharmacological Assays" comprising classical methods as well as new technologies. Before going to man, the most suitable compound has to be selected by pharmacokinetic studies and experiments in toxicology. These preclinical methods are described in the second volume ?Safety and Pharmacokinetic Assays". Only then are first studies in human beings allowed. Special rules are established for Phase I studies. Clinical pharmacokinetics are performed in parallel with human studies on tolerability and therapeutic effects. Special studies according to various populations and different therapeutic indications are necessary. These items are covered in the third volume: ?M
出版日期Living reference work 20200th edition
關(guān)鍵詞Assays; drug action; drugs; clinical pharmacology; pharmacodynamics; pharmacokinetics
doihttps://doi.org/10.1007/978-3-319-56637-5
isbn_ebook978-3-319-56637-5
The information of publication is updating

書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology影響因子(影響力)




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology影響因子(影響力)學(xué)科排名




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology網(wǎng)絡(luò)公開度




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology被引頻次




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology被引頻次學(xué)科排名




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology年度引用




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology年度引用學(xué)科排名




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology讀者反饋




書目名稱Drug Discovery and Evaluation: Methods in Clinical Pharmacology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:53:32 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:40:20 | 只看該作者
地板
發(fā)表于 2025-3-22 07:25:53 | 只看該作者
5#
發(fā)表于 2025-3-22 12:48:01 | 只看該作者
6#
發(fā)表于 2025-3-22 16:29:11 | 只看該作者
Exchange Rates: Systems and Policiesnt parameters to be considered in this context are discussed in this chapter. Since there are still certain differences between the main guidelines activities have been started to discuss the basis for science-driven regulations and to harmonize the existing requirements. In particular the Global Bi
7#
發(fā)表于 2025-3-22 17:51:14 | 只看該作者
An Agenda for International Financial Reformrate measurement of electrocardiograms (ECG) is critical for effective diagnosis of patient’s cardiac functions. Detailed examination of filters’ effects on ECG accuracy, reproducibility and robustness covering a wide range of available commercial products can provide valuable information on the rel
8#
發(fā)表于 2025-3-22 21:51:13 | 只看該作者
9#
發(fā)表于 2025-3-23 03:57:35 | 只看該作者
Helen Austerberry,Sophie Watson Advisory Network, iCAN), recruitment challenges, and research capacity building. We hereby tried to focus on recent evolutions, including initiatives to further develop this research capacity (Institute for Advanced Clinical Trials, iACT for children; Innovative Medicines Initiative, IMI2)..Perhaps
10#
發(fā)表于 2025-3-23 06:01:18 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 09:41
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
仁布县| 鹰潭市| 房山区| 松阳县| 涟源市| 布拖县| 太白县| 林周县| 乌拉特中旗| 穆棱市| 清丰县| 大洼县| 东乡族自治县| 柏乡县| 泾阳县| 琼海市| 溆浦县| 丹东市| 康马县| 吴堡县| 长岛县| 台东县| 义马市| 黄石市| 朝阳县| 汶上县| 陵水| 洛川县| 黑山县| 茌平县| 南宫市| 荆门市| 江安县| 新津县| 邯郸县| 鞍山市| 焦作市| 昌都县| 宁远县| 临朐县| 含山县|